| アブストラクト | The use of glucagon-like peptide-1 (GLP-1) receptor agonists for managing type 2 diabetes mellitus has increased, but concerns have arisen about potential risks of perioperative pulmonary aspiration. A recent study by Huang and colleagues analysed the US Food and Drug Administration Adverse Event Reporting System database, and found a significant association between GLP-1 receptor agonist use and impaired gastric emptying events, which can lead to aspiration. Recent guidelines suggest that most patients can continue taking GLP-1 receptor agonists before surgery, and those at high risk for gastrointestinal issues should follow a 24-hour liquid diet beforehand, but determining which patients are at high risk for aspiration remains a challenge for clinicians. |
|---|
| ジャーナル名 | British journal of anaesthesia |
|---|
| Pubmed追加日 | 2025/10/30 |
|---|
| 投稿者 | Ovsak, Gavin G; Gan, Tong J |
|---|
| 組織名 | Division of Anesthesiology, Critical Care and Pain Medicine, University of Texas;MD Anderson Cancer Center, Houston, TX, USA. Electronic address:;ggovsak@mdanderson.org.;tjgan@mdanderson.org. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/41162256/ |
|---|
